Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Schilling B, Schneider T, Möller I, Sucker A, Paschen A, Schadendorf D, Griewank KG.

J Transl Med. 2015;13:2057. doi: 10.1186/1479-5876-13-S1-K20. No abstract available.

2.

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma.

Zimmer L, Vaubel J, Mohr P, Hauschild A, Utikal J, Simon J, Garbe C, Herbst R, Enk A, Kämpgen E, Livingstone E, Bluhm L, Rompel R, Griewank KG, Fluck M, Schilling B, Schadendorf D.

PLoS One. 2015 Mar 11;10(3):e0118564. doi: 10.1371/journal.pone.0118564. eCollection 2015.

3.

Iron promotes protein insolubility and aging in C. elegans.

Klang IM, Schilling B, Sorensen DJ, Sahu AK, Kapahi P, Andersen JK, Swoboda P, Killilea DW, Gibson BW, Lithgow GJ.

Aging (Albany NY). 2014 Nov;6(11):975-91.

4.

The E. coli sirtuin CobB shows no preference for enzymatic and nonenzymatic lysine acetylation substrate sites.

AbouElfetouh A, Kuhn ML, Hu LI, Scholle MD, Sorensen DJ, Sahu AK, Becher D, Antelmann H, Mrksich M, Anderson WF, Gibson BW, Schilling B, Wolfe AJ.

Microbiologyopen. 2015 Feb;4(1):66-83. doi: 10.1002/mbo3.223. Epub 2014 Nov 22.

5.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Ascierto PA, Grimaldi AM, Anderson AC, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi FS, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2014 Oct 28;12:277. doi: 10.1186/s12967-014-0277-z.

6.

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.

Wilson-Edell KA, Kehasse A, Scott GK, Yau C, Rothschild DE, Schilling B, Gabriel BS, Yevtushenko MA, Hanson IM, Held JM, Gibson BW, Benz CC.

Oncotarget. 2014 Jul 15;5(13):5165-76.

7.

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study.

Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Joosse A, Schilling B, Nijsten T, Schadendorf D, de Vries E.

Cancer Med. 2014 Oct;3(5):1284-93. doi: 10.1002/cam4.285. Epub 2014 Jun 17.

8.

Structural, kinetic and proteomic characterization of acetyl phosphate-dependent bacterial protein acetylation.

Kuhn ML, Zemaitaitis B, Hu LI, Sahu A, Sorensen D, Minasov G, Lima BP, Scholle M, Mrksich M, Anderson WF, Gibson BW, Schilling B, Wolfe AJ.

PLoS One. 2014 Apr 22;9(4):e94816. doi: 10.1371/journal.pone.0094816. eCollection 2014.

9.

Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.

Zawadzka AM, Schilling B, Cusack MP, Sahu AK, Drake P, Fisher SJ, Benz CC, Gibson BW.

Mol Cell Proteomics. 2014 Apr;13(4):1034-49. doi: 10.1074/mcp.M113.035485. Epub 2014 Feb 6.

10.

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.

Griewank KG, Murali R, Schilling B, Schimming T, Möller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U.

PLoS One. 2013 Nov 18;8(11):e80354. doi: 10.1371/journal.pone.0080354. eCollection 2013.

11.
12.

Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.

Schuler PJ, Harasymczuk M, Schilling B, Saze Z, Strauss L, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2013 Dec 1;19(23):6585-96. doi: 10.1158/1078-0432.CCR-13-0900. Epub 2013 Oct 4.

13.

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men.

Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR.

BMC Pharmacol Toxicol. 2013 Oct 4;14:52. doi: 10.1186/2050-6511-14-52.

14.

Site-specific acylation changes in the lipid A of Escherichia coli lpxL mutants grown at high temperatures.

Schilling B, Hunt J, Gibson BW, Apicella MA.

Innate Immun. 2014 Apr;20(3):269-82. doi: 10.1177/1753425913490534. Epub 2013 Jun 28.

15.

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.

Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, Song M, Süsskind D, Grabellus F, Zimmer L, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zeschnigk M.

Br J Cancer. 2013 Jul 23;109(2):497-501. doi: 10.1038/bjc.2013.312. Epub 2013 Jun 25.

16.

Laccase versus laccase-like multi-copper oxidase: a comparative study of similar enzymes with diverse substrate spectra.

Reiss R, Ihssen J, Richter M, Eichhorn E, Schilling B, Thöny-Meyer L.

PLoS One. 2013 Jun 3;8(6):e65633. doi: 10.1371/journal.pone.0065633. Print 2013.

17.

Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions.

Held JM, Schilling B, D'Souza AK, Srinivasan T, Behring JB, Sorensen DJ, Benz CC, Gibson BW.

Int J Proteomics. 2013;2013:791985. doi: 10.1155/2013/791985. Epub 2013 Apr 4.

18.

Lack of SF3B1 R625 mutations in cutaneous melanoma.

Schilling B, Bielefeld N, Sucker A, Hillen U, Zimmer L, Schadendorf D, Zeschnigk M, Griewank KG.

Diagn Pathol. 2013 May 21;8:87. doi: 10.1186/1746-1596-8-87.

19.

Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).

Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, Cusack MP, Sedransk N, Hall SC, Addona T, Allen S, Dodder NG, Ghosh M, Held JM, Hedrick V, Inerowicz HD, Jackson A, Keshishian H, Kim JW, Lyssand JS, Riley CP, Rudnick P, Sadowski P, Shaddox K, Smith D, Tomazela D, Wahlander A, Waldemarson S, Whitwell CA, You J, Zhang S, Kinsinger CR, Mesri M, Rodriguez H, Borchers CH, Buck C, Fisher SJ, Gibson BW, Liebler D, Maccoss M, Neubert TA, Paulovich A, Regnier F, Skates SJ, Tempst P, Wang M, Carr SA.

Mol Cell Proteomics. 2013 Sep;12(9):2623-39. doi: 10.1074/mcp.M112.027078. Epub 2013 May 20.

20.

Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways.

Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, Li B, Schilling B, Mooney SD, Kahn CR, Verdin E, Gibson BW.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6601-6. doi: 10.1073/pnas.1302961110. Epub 2013 Apr 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk